Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Gliosarcoma 1Glioblastoma 1

Interventions

Specimen Handling 613pembrolizumab 568Magnetic Resonance Spectroscopy 538Carboplatin 429Cyclophosphamide 381Cisplatin 374Biopsy 355Paclitaxel 312Nivolumab 307Gemcitabine 302Radiotherapy 260Bevacizumab 237Dexamethasone 213fludarabine 207Docetaxel 189durvalumab 181atezolizumab 175Oxaliplatin 171Rituximab 167Fluorouracil 167venetoclax 166Pemetrexed 164Doxorubicin 161Capecitabine 158Radiation 157Radiosurgery 147Etoposide 138Leucovorin 134Ipilimumab 134Lenalidomide 132

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Sonication × 90 days × Clear all
NCT04528680 2026-04-13

SC9/ABX

Northwestern University

Phase 1/2 Active not recruiting
57 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡